Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections.

Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections.

Publication date: Oct 09, 2024

The COVID-19 pandemic posed a challenge for people living with HIV (PLWH), particularly immune non-responders (INR) with compromised CD4 T-cell reconstitution following antiretroviral therapy (CD4 count

Open Access PDF

Concepts Keywords
Cd4 Breakthrough
Hiv Cov
Pandemic Covid
Therapy Hiv
Vaccine Hybrid
Immune
Immunity
Infections
Living
Pandemic
Plwh
Posed
Sars
Therapy
Vaccine

Semantics

Type Source Name
disease MESH breakthrough infections
disease MESH COVID-19 pandemic
disease IDO cell

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *